WallStSmart

Bruker Corporation (BRKR)vsMedtronic PLC (MDT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Medtronic PLC generates 951% more annual revenue ($36.36B vs $3.46B). MDT leads profitability with a 13.2% profit margin vs -0.3%. BRKR appears more attractively valued with a PEG of 1.52. MDT earns a higher WallStSmart Score of 62/100 (C+).

BRKR

Hold

35

out of 100

Grade: F

Growth: 4.7Profit: 3.5Value: 5.0Quality: 5.5
Piotroski: 3/9Altman Z: 1.71

MDT

Buy

62

out of 100

Grade: C+

Growth: 6.7Profit: 6.5Value: 5.3Quality: 6.5
Piotroski: 5/9Altman Z: 1.99
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BRKRUndervalued (+4.9%)

Margin of Safety

+4.9%

Fair Value

$44.60

Current Price

$56.53

$11.93 discount

UndervaluedFair: $44.60Overvalued
MDTUndervalued (+12.1%)

Margin of Safety

+12.1%

Fair Value

$91.70

Current Price

$81.67

$10.03 discount

UndervaluedFair: $91.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BRKR0 strengths · Avg: 0/10

No standout strengths identified

MDT4 strengths · Avg: 8.3/10
Market CapQuality
$103.20B9/10

Large-cap with strong market position

Price/BookValuation
2.1x8/10

Reasonable price relative to book value

Operating MarginProfitability
21.3%8/10

Strong operational efficiency at 21.3%

Free Cash FlowQuality
$2.08B8/10

Generating 2.1B in free cash flow

Areas to Watch

BRKR4 concerns · Avg: 3.8/10
PEG RatioValuation
1.524/10

Expensive relative to growth rate

Revenue GrowthGrowth
2.7%4/10

2.7% revenue growth

Altman Z-ScoreHealth
1.714/10

Distress zone — elevated risk

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

MDT2 concerns · Avg: 4.0/10
PEG RatioValuation
1.594/10

Expensive relative to growth rate

Altman Z-ScoreHealth
1.994/10

Grey zone — moderate risk

Comparative Analysis Report

WallStSmart Research

Bull Case : BRKR

BRKR has a balanced fundamental profile.

Bull Case : MDT

The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin.

Bear Case : BRKR

The primary concerns for BRKR are PEG Ratio, Revenue Growth, Altman Z-Score.

Bear Case : MDT

The primary concerns for MDT are PEG Ratio, Altman Z-Score.

Key Dynamics to Monitor

BRKR profiles as a turnaround stock while MDT is a value play — different risk/reward profiles.

BRKR carries more volatility with a beta of 1.30 — expect wider price swings.

MDT is growing revenue faster at 9.9% — sustainability is the question.

MDT generates stronger free cash flow (2.1B), providing more financial flexibility.

Bottom Line

MDT scores higher overall (62/100 vs 35/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Bruker Corporation

HEALTHCARE · MEDICAL DEVICES · USA

Bruker Corporation develops, manufactures and distributes scientific instruments and analytical and diagnostic solutions in the United States, Europe, Asia Pacific, and internationally. The company is headquartered in Billerica, Massachusetts.

Visit Website →

Medtronic PLC

HEALTHCARE · MEDICAL DEVICES · USA

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.

Want to dig deeper into these stocks?